Neurocrine to conduct placebo-controlled study to investigate potential new treatment for schizophrenia
A phase 2 clinical trial for the treatment of schizophrenia has been accepted by the…
August 5, 2022 - 3 minutes
A phase 2 clinical trial for the treatment of schizophrenia has been accepted by the…